According to GuruFocus' list of 52-week highs, these Guru stocks have reached their 52-Week Highs: Kimberly-Clark Corp. (KMB, Financial), Abbott Laboratories (ABT, Financial), Alexion Pharmaceuticals Inc. (ALXN, Financial), William Partners LP (WPZ, Financial), and News Corp. (NWSA, Financial).
Kimberly-Clark Corp. (KMB) Reached the 52-Week High of $72.63
Kimberly-Clark Corporation is one of the largest consumer products companies. Kimberly-Clark Corp. has a market cap of $28.62 billion; its shares were traded at around $72.63 with a P/E ratio of 15.5 and P/S ratio of 1.5. The dividend yield of Kimberly-Clark Corp. stocks is 3.8%. Kimberly-Clark Corp. had an annual average earnings growth of 4.3% over the past 10 years. GuruFocus rated KimberlyClark Corp. the business predictability rank of 2.5-star.
On October 24, Kimberly-Clark Corporation reported third quarter 2011 results. Third quarter 2011 net sales were an all-time record $5.4 billion and increased 8 percent. Organic sales, which exclude the impact of changes in foreign currency rates, rose 4 percent, driven by higher net selling prices. Diluted net income per share for the quarter was $1.09 compared with $1.14 in the year-ago period. Third quarter adjusted earnings per share were $1.26 in 2011.
Last month, Senior Vice President Continuous Improvement Jan Bc Spencer sold 39,283 shares of KMB stock. President, K-C Healthcare Joanne B. Bauer, President, K-C Professional Christian A. Brickman, Director Linda Johnson Rice, and Chairman of the Board and CEO Thomas J. Falk sold shares in November.
Abbott Laboratories (ABT) Reached the 52-Week High of $55.86
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott Laboratories has a market cap of $87.02 billion; its shares were traded at around $55.86 with a P/E ratio of 12.5 and P/S ratio of 2.5. The dividend yield of Abbott Laboratories stocks is 3.4%. Abbott Laboratories had an annual average earnings growth of 7.8% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 5-star.
On October 19, Abbott announced financial results for the third quarter ended Sept. 30, 2011. Diluted earnings per share, excluding specified items, were $1.18, at the high end of Abbott's previous guidance range, reflecting 12.4 percent growth. Worldwide sales increased 13.2 percent to $9.8 billion, including a favorable 5.3 percent effect of foreign exchange.
Last month, Chairman and CEO Miles D. White, Senior Vice President Heather L. Mason, Vice President Greg W. Linder, Senior Vice President Michael J. Warmuth, Senior Vice President Carlos Alban, and Senior Vice President Mary T. Szela sold shares of ABT stock.
Alexion Pharmaceuticals Inc. (ALXN) Reached the 52-Week High of $74.45
Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. Alexion Pharmaceuticals Inc. has a market cap of $13.78 billion; its shares were traded at around $74.45 with a P/E ratio of 72.7 and P/S ratio of 25.5.
For the three months ended Sept. 30, 2011, Alexion Pharmaceuticals Inc. reported total revenues of $204.0 million from net product sales of Soliris® (eculizumab), compared to $141.6 million in Q3 2010, reflecting steady addition of new patients with paroxysmal nocturnal hemoglobinuria (PNH) during the quarter. The Company reported GAAP net income for Q3 2011 of $65.6 million, or $0.34 per share, compared to $27.9 million, or $0.15 per share, in the third quarter of 2010.
CEO Leonard Bell, Senior Vice President of Global Commercial Operations David Hallal, and Senior Vice President and President ALXN Pharma Int'l Patrice Coissac sold shares of ALXN stock in November. Director Alvin S. Parven, Director R. Douglas Norby, and Executive Vice President of Research and Development Stephen P. Squinto sold shares in October.
Williams Partners LP (WPZ) Reached the 52-Week High of $62.57
Williams Partners, through its subsidiaries, primarily finds, produces, gathers, processes and transports natural gas. Williams Partners LP has a market cap of $18.18 billion; its shares were traded at around $62.57 with a P/E ratio of 18.4 and P/S ratio of 3.2. The dividend yield of Williams Partners L.P. stocks is 4.7%. Williams Partners LP had an annual average earnings growth of 20.6% over the past five years.
On November 1, Williams Partners LP announced unaudited third-quarter 2011 net income of $342 million, or $0.91 per common limited-partner unit, compared with third-quarter 2010 net income of $253 million, or $0.63 per common unit.
News Corp. (NWSA) Reached the 52-Week High of $18.3
News Corp. is a diversified entertainment company with operations in eight industry segments: filmed entertainment; television; cable network programming; direct broadcast satellite television; magazines and inserts; newspapers and information services; book publishing; and other. News Corp. has a market cap of $31.51 billion; its shares were traded at around $18.3 with a P/E ratio of 14.9 and P/S ratio of 0.9. The dividend yield of News Corp. stocks is 1%.
On November 2, News Corporation reported total revenue for the first quarter of fiscal 2012 of $7.96 billion, an increase of $533 million or 7% over the $7.43 billion reported a year ago. The company reported first quarter net income of $738 million ($0.28 per share), as compared to net income of $775 million ($0.30 per share) reported a year ago.
Kimberly-Clark Corp. (KMB) Reached the 52-Week High of $72.63
Kimberly-Clark Corporation is one of the largest consumer products companies. Kimberly-Clark Corp. has a market cap of $28.62 billion; its shares were traded at around $72.63 with a P/E ratio of 15.5 and P/S ratio of 1.5. The dividend yield of Kimberly-Clark Corp. stocks is 3.8%. Kimberly-Clark Corp. had an annual average earnings growth of 4.3% over the past 10 years. GuruFocus rated KimberlyClark Corp. the business predictability rank of 2.5-star.
On October 24, Kimberly-Clark Corporation reported third quarter 2011 results. Third quarter 2011 net sales were an all-time record $5.4 billion and increased 8 percent. Organic sales, which exclude the impact of changes in foreign currency rates, rose 4 percent, driven by higher net selling prices. Diluted net income per share for the quarter was $1.09 compared with $1.14 in the year-ago period. Third quarter adjusted earnings per share were $1.26 in 2011.
Last month, Senior Vice President Continuous Improvement Jan Bc Spencer sold 39,283 shares of KMB stock. President, K-C Healthcare Joanne B. Bauer, President, K-C Professional Christian A. Brickman, Director Linda Johnson Rice, and Chairman of the Board and CEO Thomas J. Falk sold shares in November.
Abbott Laboratories (ABT) Reached the 52-Week High of $55.86
Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott Laboratories has a market cap of $87.02 billion; its shares were traded at around $55.86 with a P/E ratio of 12.5 and P/S ratio of 2.5. The dividend yield of Abbott Laboratories stocks is 3.4%. Abbott Laboratories had an annual average earnings growth of 7.8% over the past 10 years. GuruFocus rated Abbott Laboratories the business predictability rank of 5-star.
On October 19, Abbott announced financial results for the third quarter ended Sept. 30, 2011. Diluted earnings per share, excluding specified items, were $1.18, at the high end of Abbott's previous guidance range, reflecting 12.4 percent growth. Worldwide sales increased 13.2 percent to $9.8 billion, including a favorable 5.3 percent effect of foreign exchange.
Last month, Chairman and CEO Miles D. White, Senior Vice President Heather L. Mason, Vice President Greg W. Linder, Senior Vice President Michael J. Warmuth, Senior Vice President Carlos Alban, and Senior Vice President Mary T. Szela sold shares of ABT stock.
Alexion Pharmaceuticals Inc. (ALXN) Reached the 52-Week High of $74.45
Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. Alexion Pharmaceuticals Inc. has a market cap of $13.78 billion; its shares were traded at around $74.45 with a P/E ratio of 72.7 and P/S ratio of 25.5.
For the three months ended Sept. 30, 2011, Alexion Pharmaceuticals Inc. reported total revenues of $204.0 million from net product sales of Soliris® (eculizumab), compared to $141.6 million in Q3 2010, reflecting steady addition of new patients with paroxysmal nocturnal hemoglobinuria (PNH) during the quarter. The Company reported GAAP net income for Q3 2011 of $65.6 million, or $0.34 per share, compared to $27.9 million, or $0.15 per share, in the third quarter of 2010.
CEO Leonard Bell, Senior Vice President of Global Commercial Operations David Hallal, and Senior Vice President and President ALXN Pharma Int'l Patrice Coissac sold shares of ALXN stock in November. Director Alvin S. Parven, Director R. Douglas Norby, and Executive Vice President of Research and Development Stephen P. Squinto sold shares in October.
Williams Partners LP (WPZ) Reached the 52-Week High of $62.57
Williams Partners, through its subsidiaries, primarily finds, produces, gathers, processes and transports natural gas. Williams Partners LP has a market cap of $18.18 billion; its shares were traded at around $62.57 with a P/E ratio of 18.4 and P/S ratio of 3.2. The dividend yield of Williams Partners L.P. stocks is 4.7%. Williams Partners LP had an annual average earnings growth of 20.6% over the past five years.
On November 1, Williams Partners LP announced unaudited third-quarter 2011 net income of $342 million, or $0.91 per common limited-partner unit, compared with third-quarter 2010 net income of $253 million, or $0.63 per common unit.
News Corp. (NWSA) Reached the 52-Week High of $18.3
News Corp. is a diversified entertainment company with operations in eight industry segments: filmed entertainment; television; cable network programming; direct broadcast satellite television; magazines and inserts; newspapers and information services; book publishing; and other. News Corp. has a market cap of $31.51 billion; its shares were traded at around $18.3 with a P/E ratio of 14.9 and P/S ratio of 0.9. The dividend yield of News Corp. stocks is 1%.
On November 2, News Corporation reported total revenue for the first quarter of fiscal 2012 of $7.96 billion, an increase of $533 million or 7% over the $7.43 billion reported a year ago. The company reported first quarter net income of $738 million ($0.28 per share), as compared to net income of $775 million ($0.30 per share) reported a year ago.
